mTORC1 promotes malignant large cell/anaplastic histology and is a targetable vulnerability in SHH-TP53 mutant medulloblastoma.

MLA

Conti, Valentina, et al. “MTORC1 Promotes Malignant Large Cell/Anaplastic Histology and Is a Targetable Vulnerability in SHH-TP53 Mutant Medulloblastoma.” JCI Insight, vol. 6, no. 23, Dec. 2021. EBSCOhost, https://doi.org/10.1172/jci.insight.153462.

APA

Conti, V., Cominelli, M., Pieri, V., Gallotti, A. L., Pagano, I., Zanella, M., Mazzoleni, S., Pivetta, F., Patanè, M., Scotti, G. M., Piras, I. S., Pollo, B., Falini, A., Zippo, A., Castellano, A., Maestro, R., Poliani, P. L., & Galli, R. (2021). mTORC1 promotes malignant large cell/anaplastic histology and is a targetable vulnerability in SHH-TP53 mutant medulloblastoma. JCI Insight, 6(23). https://doi.org/10.1172/jci.insight.153462

Chicago

Conti, Valentina, Manuela Cominelli, Valentina Pieri, Alberto L Gallotti, Ilaria Pagano, Matteo Zanella, Stefania Mazzoleni, et al. 2021. “MTORC1 Promotes Malignant Large Cell/Anaplastic Histology and Is a Targetable Vulnerability in SHH-TP53 Mutant Medulloblastoma.” JCI Insight 6 (23). doi:10.1172/jci.insight.153462.